Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases
- Authors
-
-
Fabio Franceschini Mitri
Department of Human Anatomy, Institute of Biomedical Sciences, Federal University of Uberlandia, Uberlandia/MG, Brazil
-
- Keywords:
- Nanotechnology, Nanomedicine, Nanodrugs, Bone Cancer, Osteosarcoma, Bone Infection, Osteoarthritis, Targeted Delivery.
- Abstract
-
The ever-evolving field of nanotechnology has been applied over the years as an amazing potential tool in bone disorders through the development of targeted drug nanosystems. Bone diseases can be referred as any bone condition able to cause morbidity or even mortality to the host. Osteosarcoma has been most investigated condition for management and treatment by nanomedicine, and several nanomaterials such as nanoparticles, nanocapsules, nanospheres, nanodiamonds are being used for drug delivery. Likewise, other bone diseases, such as osteoporosis, osteonecrosis, osteoarthritis, bone tuberculosis have received nanotherapy with a large rate of success. The nanomedicine seems to make up a targeting lack by conventional therapy and chemotherapy, besides appointing to a trend of conservative clinical treatment, especially for severe disorders. Additionally, nanomedicine has advanced over the years, therefore, there is a strong need to accelerate its application in bone diseases reducing the mortality rate related to these conditions. This review article provides an overview on the advances of nanotechnology over the last two decades and highlights the pathways of investigations for targeted delivery nanoensembles.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 30-12-2021
- Issue
- Vol. 10 (2021)
- Section
- Articles
How to Cite
Similar Articles
- Parvin Mehdipour, Multi-Phase Based Signature and Cancer Management: An Insight in Embryo, Brain Tumor, Leukemia, and Von Hippel Lindau Syndrome , Journal of Cancer Research Updates: Vol. 12 (2023)
- Kathryn A. Bailey, Kathleen Wallace, Lisa Smeester, Sheau-Fung Thai, Douglas C. Wolf, Stephen W. Edwards, Rebecca C. Fry, Transcriptional Modulation of the ERK1/2 MAPK and NF-kB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Yang-Hui Huang, Sung-Han Hsiao, Chung-Pu Wu, Isoreserpine Reverses Multidrug Resistance Mediated by ABCB1 , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Hossein Mozdarani, Zainab Kouchak Mashkdouz, The Potent Regulatory Role of Circular RNAs in Breast Cancer Development, Diagnosis and Treatment: An Update , Journal of Cancer Research Updates: Vol. 11 (2022)
- Emmanuel Mendoza, José Roberto Prieto Correa , José Alfonso Cruz Ramos , Paola Monserrat Zepeda Olmos , Juan José Soto Ávila , Sandra López Verdín , The Concentration Levels of ATP in Oral Squamous Cell Carcinoma Tissues and Risk Habits Involved: An Experimental Study , Journal of Cancer Research Updates: Vol. 15 No. 2 (2026)
- Simona Di Francesco, Raffaele L. Tenaglia, Vascular Disease and Prostate Cancer: A Conflicting Association , Journal of Cancer Research Updates: Vol. 3 No. 1 (2014)
- Kamlesh Sodani, Amit K. Tiwari, Chun-Ling Dai, Alaa H. Abuznait, Atish Patel, Zhi-Jie Xiao, Charles R. Ashby, Amal Kaddoumi, Li-Wu Fu, Zhe-Sheng Chen, Sildenafil Enhances the Anticancer Activity of Paclitaxel in an ABCB1-Mediated Multidrug Resistance Xenograft Mouse Model , Journal of Cancer Research Updates: Vol. 3 No. 3 (2014)
- L.R. Morgan, R.S. Weiner, M.L. Ware, M. Bhandari, T. Mahmood, P. Friedlander, Early Phase I Results for 4-Demethyl-4-cholesteryloxypenclo-medine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies , Journal of Cancer Research Updates: Vol. 7 No. 3 (2018)
- Amy Zhong, Melissa Chang, Theresa Yu, Raymond Gau, Daniel J. Riley, Yumay Chen, Phang-Lang Chen, Aberrant DNA Damage Response and DNA Repair Pathway in High Glucose Conditions , Journal of Cancer Research Updates: Vol. 7 No. 3 (2018)
- Fatima Mohamed Osman, Weam Alyoubi, Tarteel Mohammed Ahmed, Jo'rayeva Gulhayo Jalol Qizi, Nagat Bashir Siednamohammeddeen Ahmed, Nada Osman Yousif Elhaj, Tagwa Yousif Elsayed Yousif, Marwan Ismail, Repurposing the Antiparasitic Agent Praziquantel for Breast Neoplasm Therapy: A Narrative Review of the Mechanistic Rationale, Current Evidence and Translational Barriers , Journal of Cancer Research Updates: Vol. 15 No. 3 (2026)
You may also start an advanced similarity search for this article.